MetLife Announces First Quarter 2019 Preferred Stock Dividend Actions
- 64
MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends:
- Semi-annual dividend of $29.375 per share on the company’s 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share.
- Quarterly dividend of $351.5625 per share on the company’s 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares (NYSE: METPrE) each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share.
- Quarterly dividend of $0.25 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: METPrA), subject to the final confirmation that the company has met the financial tests specified in the certificate of designations for the Series A preferred stock, which the company anticipates will be made and announced on or about March 5, 2019. The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock, and will set an ex-dividend date after the confirmatory announcement.
The above dividends will be payable March 15, 2019, to shareholders of record as of Feb. 28, 2019.
About MetLife
MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers navigate their changing world. Founded in 1868, MetLife has operations in more than 40 countries and holds leading market positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.
Forward-Looking Statements
This news release may contain or refer to forward-looking statements. Forward-looking statements give expectations or forecasts of the future using terms such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will,” and other terms tied to future periods. Results could differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements are based on assumptions and expectations. They involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. The company has no obligation to correct or update any forward-looking statement. Parts of this news release may include additional information on forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190215005348/en/
- Photocat call for General assembly 22nd May 2024 at 16:00
- EQS-News: Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.
- NORBIT ASA – Minutes from NORBIT ASA's Annual General Meeting 2024
- WiMi Developed a Swin-Transformer and Hash-based On-Chain Copyright Detection Technology
- EXEL Industries: Number of shares and voting rights as of 03.31.2024
- Mohammad Bahareth Consultancy & Research Office Honored: Founder Wins 2023 Business Consultant of the Year